Trading Signals: IOVA Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Iovance Biotherapeutics Inc)
| IOVA latest price $5.9150 (0.17%) ($5.9150 - $5.9150) on Sun. Apr. 9, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.18% (three month average) | RSI | 43 | Latest Price | $5.9150(0.17%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | IOVA declines -0.8% a day on average for past five trading days. | Weekly Trend | IOVA declines -1.2% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support IOVA advance at 0% a week (0% probability) (0%) (0%) (0%) (0%) (0%) | Factors Impacting IOVA price | IOVA will decline at least -2.09% in a week (0% probabilities). (0%) (0%) (0%) (0%) (0%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.09% (StdDev 4.18%) | Hourly BBV | 0 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-4.38(-174.05%) | Resistance Level | $6.21 | 5 Day Moving Average | $6.01(-1.58%) | 10 Day Moving Average | $6.08(-2.71%) | 20 Day Moving Average | $6.21(-4.75%) | To recent high | -28.2% | To recent low | 7.2% | Market Cap | $N/A | | | | Iovance Biotherapeutics, Inc. operates as a biotechnology company. The firm engages in the development and commercialization of novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes, or TIL, which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA. |